LONDON (Reuters) - French drugmaker Sanofi is to stop selling an inhalable insulin developed by Mannkind, following disappointing sales of the product since its launch in February 2015.
http://ift.tt/1Oxhdet
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire